[Treatment of cardiogenic shock following myocardial infarct].
D001243:Assisted Circulation; D001026:Coronary Artery Bypass; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007773:Lactates / Q000378:metabolism; D009921:Metaproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009204:Myocardial Revascularization; D009638:Norepinephrine / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*
D004071:Digitalis Glycosides; D005343:Fibrinolytic Agents; D007773:Lactates; D009921:Metaproterenol; D009638:Norepinephrine
Die Behandlung des kardiogenen Schocks nach Herzinfarkt.